Literature DB >> 19085069

CMV enhancer-promoter is preferentially active in exocrine cells in vivo.

D B Vasey1, S G Lillico, H M Sang, T J King, C B A Whitelaw.   

Abstract

The CMV enhancer-promoter sequence is often used as a transcriptional regulatory element in vector systems. We have used this control element to drive expression of GFP in a lentivirus vector transgene in pigs and chickens. Promoted as a 'universal' enhancer/promoter element capable of transcriptional activity in a number of cells in vitro, CMV-GFP transgene expression in vivo is preferentially observed in exocrine cells. This expression profile validates the use of this transcriptional control sequence to target expression to exocrine cells in gene transfer strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085069     DOI: 10.1007/s11248-008-9235-y

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  20 in total

Review 1.  Lentiviral transgenesis.

Authors:  Alexander Pfeifer
Journal:  Transgenic Res       Date:  2004-12       Impact factor: 2.788

2.  The cytomegalovirus enhancer: a pan-active control element in transgenic mice.

Authors:  E V Schmidt; G Christoph; R Zeller; P Leder
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  Powerful and versatile enhancer-promoter unit for mammalian expression vectors.

Authors:  M K Foecking; H Hofstetter
Journal:  Gene       Date:  1986       Impact factor: 3.688

4.  Efficient production of germline transgenic chickens using lentiviral vectors.

Authors:  Michael J McGrew; Adrian Sherman; Fiona M Ellard; Simon G Lillico; Hazel J Gilhooley; Alan J Kingsman; Kyriacos A Mitrophanous; Helen Sang
Journal:  EMBO Rep       Date:  2004-06-11       Impact factor: 8.807

5.  The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice.

Authors:  P A Furth; L Hennighausen; C Baker; B Beatty; R Woychick
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

6.  Multistep, sequential control of the trafficking and function of the multiple sulfatase deficiency gene product, SUMF1 by PDI, ERGIC-53 and ERp44.

Authors:  Alessandro Fraldi; Ester Zito; Fabio Annunziata; Alessia Lombardi; Marianna Cozzolino; Maria Monti; Carmine Spampanato; Andrea Ballabio; Piero Pucci; Roberto Sitia; Maria Pia Cosma
Journal:  Hum Mol Genet       Date:  2008-05-28       Impact factor: 6.150

7.  Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.

Authors:  J Kong; S-R Kim; K Binley; I Pata; K Doi; J Mannik; J Zernant-Rajang; O Kan; S Iqball; S Naylor; J R Sparrow; P Gouras; R Allikmets
Journal:  Gene Ther       Date:  2008-05-08       Impact factor: 5.250

8.  NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.

Authors:  L C Sambucetti; J M Cherrington; G W Wilkinson; E S Mocarski
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

Review 9.  The B-cell system of human mucosae and exocrine glands.

Authors:  P Brandtzaeg; I N Farstad; F E Johansen; H C Morton; I N Norderhaug; T Yamanaka
Journal:  Immunol Rev       Date:  1999-10       Impact factor: 12.988

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  3 in total

1.  Welfare assessment in transgenic pigs expressing green fluorescent protein (GFP).

Authors:  Reinhard C Huber; Liliana Remuge; Ailsa Carlisle; Simon Lillico; Peter Sandøe; Dorte B Sørensen; C Bruce A Whitelaw; I Anna S Olsson
Journal:  Transgenic Res       Date:  2011-12-16       Impact factor: 2.788

2.  Lentiviral transgenesis in livestock.

Authors:  Simon Lillico; Douglas Vasey; Tim King; Bruce Whitelaw
Journal:  Transgenic Res       Date:  2010-10-07       Impact factor: 2.788

3.  Characterisation of eGFP-transgenic BALB/c mouse strain established by lentiviral transgenesis.

Authors:  Krisztián Kvell; Tamás Czömpöly; László Hiripi; Péter Balogh; József Kóbor; Lilla Bodrogi; Judit E Pongrácz; William A Ritchie; Zsuzsanna Bosze
Journal:  Transgenic Res       Date:  2009-05-31       Impact factor: 2.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.